20213

    0

    SUNREST

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    SUNREST LIFESCIENCE LTD Share Price Today

    SUNREST LIFESCIENCE LTD is currently trading at ₹35, up by ₹0.0 from the previous close. The stock touched an intraday high of ₹35.00 and a low of ₹35.00 during the latest trading session. Over the past one year, SUNREST LIFESCIENCE LTD has delivered a loss of 35.17%, while the stock has gained 7.52% in the last one month.

    SUNREST LIFESCIENCE LTD performance

    Today’s low Today’s high
    ₹ 35.00 ₹ 35.00
    ₹ 35.00
    52 week low 52 week high
    ₹ 26.37 ₹ 51.58
    ₹ 35.00
    Open Price ₹ 35.00
    Prev. Close ₹ 35.00
    Volume (Shares) 1600.00
    Total traded value ₹ .56
    Upper Circuit ₹ 42.00
    Lower Circuit ₹ 28.00
    info

    Investment Returns

    Over 1 Month 7.52% Over 3 Months -4.89% Over 6 Months 18.84% Over 1 Year -35.17%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    SUNREST LIFESCIENCE LTD fundamentals


    • Market cap (Cr) 30.00
    • P/E Ratio (TTM) 9.72
    • Beta 0.45
    • Book Value / share 27.45
    • Return on equity 13.18%
    • EPS (TTM) 3.60
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 1.23
    info icon alternate text
    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) [-]
    info icon alternate text

    SUNREST LIFESCIENCE LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars SEP 2023 (Values in Cr)
    Revenue 6.84
    Operating Expense 0.00
    Net Profit 1.23
    Net Profit Margin (%) 17.98
    Earnings Per Share (EPS) 4.12
    EBITDA 0.00
    Effective Tax Rate (%) 0.00
    Particulars JUN 2023 (Values in Cr)
    Revenue 5.64
    Operating Expense 4.67
    Net Profit 0.75
    Net Profit Margin (%) 13.29
    Earnings Per Share (EPS) 2.50
    EBITDA 1.00
    Effective Tax Rate (%) 22.68
    Particulars MAR 2023 (Values in Cr)
    Revenue 6.84
    Operating Expense 0.00
    Net Profit -0.32
    Net Profit Margin (%) -4.67
    Earnings Per Share (EPS) 0.00
    EBITDA 0.00
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 33.26
    Operating Expense 29.18
    Net Profit 3.09
    Net Profit Margin (%) 9.29
    Earnings Per Share (EPS) 7.20
    EBITDA 4.82
    Effective Tax Rate (%) 24.26
    Particulars MAR 2025 (Values in Cr)
    Revenue 33.12
    Operating Expense 30.51
    Net Profit 2.00
    Net Profit Margin (%) 6.03
    Earnings Per Share (EPS) 4.66
    EBITDA 2.99
    Effective Tax Rate (%) 23.37
    Particulars MAR 2024 (Values in Cr)
    Revenue 29.48
    Operating Expense 28.89
    Net Profit 0.23
    Net Profit Margin (%) 0.78
    Earnings Per Share (EPS) 0.68
    EBITDA 0.90
    Effective Tax Rate (%) 62.71
    Particulars MAR 2023 (Values in Cr)
    Revenue 24.64
    Operating Expense 21.93
    Net Profit 2.04
    Net Profit Margin (%) 8.27
    Earnings Per Share (EPS) 6.81
    EBITDA 2.93
    Effective Tax Rate (%) 25.54
    Particulars MAR 2022 (Values in Cr)
    Revenue 26.89
    Operating Expense 25.86
    Net Profit 0.78
    Net Profit Margin (%) 2.90
    Earnings Per Share (EPS) 777.10
    EBITDA 1.12
    Effective Tax Rate (%) 25.71
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 37.72
    ROE % 13.18
    ROCE % 13.53
    Total Debt to Total Equity 0.41
    EBITDA Margin 9.06
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 33.06
    ROE % 2.66
    ROCE % 6.41
    Total Debt to Total Equity 0.48
    EBITDA Margin 3.09
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 10.38
    ROE % 97.61
    ROCE % 58.58
    Total Debt to Total Equity 1.29
    EBITDA Margin 11.89
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 1070.40
    ROE % 114.71
    ROCE % 30.92
    Total Debt to Total Equity 4.09
    EBITDA Margin 4.20
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 294.90
    ROE % 80.95
    ROCE % 9.58
    Total Debt to Total Equity 10.93
    EBITDA Margin 1.65
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.27
    Total Assets 35.15
    Total Liabilities 35.15
    Total Equity 16.18
    Share Outstanding 0
    Price to Book Ratio 1.42
    Return on Assets (%) 5.68
    Return on Capital (%) 8.95
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.28
    Total Assets 25.15
    Total Liabilities 25.15
    Total Equity 14.18
    Share Outstanding 0
    Price to Book Ratio 1.85
    Return on Assets (%) 0.89
    Return on Capital (%) 1.11
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.44
    Total Assets 16.71
    Total Liabilities 16.71
    Total Equity 3.11
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 12.22
    Return on Capital (%) 38.87
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.48
    Total Assets 13.01
    Total Liabilities 13.01
    Total Equity 1.07
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 5.96
    Return on Capital (%) 18.04
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.37
    Total Assets 9.48
    Total Liabilities 9.48
    Total Equity 0.29
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 1.74
    Return on Capital (%) 6.34
    Particulars MAR 2025 (Values in Cr)
    Net Income 2.60
    Cash from Operations 1.90
    Cash from Investing -1.13
    Cash from Financing -0.29
    Net change in Cash -0.01
    Free Cash Flow 3.27
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.59
    Cash from Operations -13.96
    Cash from Investing 0.00
    Cash from Financing 14.64
    Net change in Cash -0.16
    Free Cash Flow -13.95
    Particulars MAR 2023 (Values in Cr)
    Net Income 2.74
    Cash from Operations 1.53
    Cash from Investing -0.03
    Cash from Financing -1.15
    Net change in Cash -0.03
    Free Cash Flow 1.54
    Particulars MAR 2022 (Values in Cr)
    Net Income 1.05
    Cash from Operations -0.35
    Cash from Investing -0.35
    Cash from Financing 0.89
    Net change in Cash 0.10
    Free Cash Flow 0.11
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.22
    Cash from Operations 0.22
    Cash from Investing -0.16
    Cash from Financing 0.03
    Net change in Cash 0.02
    Free Cash Flow 0.38
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.80 13.20 1.53 243.69 23.12 38.85
    BLISS GVS PHARMA LTD 461.00 37.06 4.09 4889.19 118.35 552.90
    CIPLA LTD. 1409.85 31.83 3.30 113894.07 1165.55 1672.20
    FERMENTA BIOTECH LTD. 444.00 20.77 3.21 1306.74 256.40 480.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.80 22.24 4.09 243.69 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 513.60 23.02 4.01 1484.85 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8167.90 106.74 23.39 20419.75 7630.00 9850.00
    BLISS GVS PHARMA LTD 461.00 49.84 4.23 4889.19 118.35 552.90

    SUNREST LIFESCIENCE LTD shareholding pattern

    Holding
    46.49%
    53.5%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    SUNREST LIFESCIENCE LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    35.00 0.00 redarrow
    red-green-graph indicator
    13 Bearish
    3 Bullish
    • 5 Days 34.80
    • 26 Days 35.30
    • 10 Days 34.60
    • 50 Days 36.10
    • 12 Days 34.70
    • 100 Days 37.90
    • 20 Days 35.00
    • 200 Days 42.20
    35.00 PIVOT
    First Support 35.00 First Resistance 35.00 Second Support 35.00 Second Resistance 35.00 Third Support 35.00 Third Resistance 35.00
    RSI 48.85 ADX 9.18 MACD -0.62 Williams % R -38.71 Commodity Channel Index (CCI) -11.12
    Date 2026-07-23 Week 1600.00 Same Day 1600.00 Month 2133.00
    1 Year 0.46 3 Year 0.75
    Over 1 Month
    7.52% down
    Over 1 Year
    -35.17% down
    Over 3 Months
    -4.89% down
    Over 3 Years
    -21.08% down
    Over 6 Months
    18.84% down
    Over 5 Years
    0.00% down

    SUNREST LIFESCIENCE LTD Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Sunrest Lifescience Ltd?

    Answer Field

    Sunrest Lifescience Ltd share price is for NSE ₹ 35.00 & for BSE ₹ 0.00 as on Jul 23 2026 02:50 PM.

    What is the Market Cap of Sunrest Lifescience Ltd Share?

    Answer Field

    The market cap of Sunrest Lifescience Ltd for NSE ₹ 30.00 & for BSE ₹ 0.00 as on Jul 23 2026 02:50 PM.

    What is the 52 Week High and Low of Sunrest Lifescience Ltd?

    Answer Field

    The 52 Week High and Low of Sunrest Lifescience Ltd for NSE is ₹ 51.58 and ₹ 26.37 and for BSE is ₹ 0.00 and ₹ 0.00.

    What is 1 year return for Sunrest Lifescience Ltd?

    Answer Field

    The 1 year returns on the stock has been -35.17%.

    What is the P/E Ratio of Sunrest Lifescience Ltd Share?

    Answer Field

    As on Jul 23 2026 02:50 PM the price-to-earnings (PE) ratio for Sunrest Lifescience Ltd share is 9.72.

    What is the PB ratio of Sunrest Lifescience Ltd Share?

    Answer Field

    As on Jul 23 2026 02:50 PM, the price-to-book (PB) ratio for Sunrest Lifescience Ltd share is 27.45.

    How to Buy Sunrest Lifescience Ltd Share?

    Answer Field

    You can trade in Sunrest Lifescience Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Sunrest Lifescience Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Sunrest Lifescience Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Sunrest Lifescience Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |